Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines
Authors:
Open Access
- 1 May 2010
- journal article
- practice guideline
- Published by Elsevier in Annals of Oncology
- Vol. 21 (suppl_5) , v261-v265
Abstract
Oral and gastrointestinal mucositis due to cancer therapies such as high-dose chemotherapy and/or radiation continues to be an important clinical problem. Fortunately, there have been strategic advances over the past decade relative to understanding the molecular basis of the injury, opportunities for development of drugs and devices to prevent or treat the toxicity, and clinical guideline development. The following text addresses this paradigm, with focus on evidence-based guidelines as developed by the Multinational Association of Supportive Care in Cancer (MASCC) in collaboration with the International Society of Oral Oncology (ISOO).Keywords
This publication has 22 references indexed in Scilit:
- Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapyCancer, 2008
- Phase I Study of Paclitaxel and Uracil plus Tegafur Combination in Patients with Pretreated Metastatic Breast Cancer: Drug Sequencing Based on Preclinical Modelling StudiesOncology, 2007
- Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based ChemotherapyJournal of Clinical Oncology, 2006
- Mucosal injury from targeted anti-cancer therapySupportive Care in Cancer, 2006
- Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practiceSupportive Care in Cancer, 2006
- Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancerSupportive Care in Cancer, 2006
- Prevention and Management of Hereditary Breast CancerJournal of Clinical Oncology, 2005
- Perspectives on cancer therapy-induced mucosal injuryCancer, 2004
- Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx CarcinomaJournal of Clinical Oncology, 2004
- Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression AnalysisActa Oncologica, 1998